{"id":3418,"date":"2021-05-27T16:10:06","date_gmt":"2021-05-27T16:10:06","guid":{"rendered":"https:\/\/biotechsa.com\/2\/?p=3418"},"modified":"2026-03-10T13:00:39","modified_gmt":"2026-03-10T19:00:39","slug":"obesity-protects-against-death-in-severe-bacterial-infection","status":"publish","type":"post","link":"https:\/\/biotechsa.com\/2\/noticias\/obesity-protects-against-death-in-severe-bacterial-infection\/","title":{"rendered":"Obesity protects against death in severe bacterial infection"},"content":{"rendered":"\n
<\/span><\/div>

According to Science Daily, a new study shows that \u201ca higher BMI may be linked to higher survival rates in patients hospitalized for severe bacterial infections.\u201d Scientists from Sahlgrenska Academy, University of Gothenburg, and Skaraborg Hospital in Sk\u00f6vde, observed 2,196 adult patients receiving care for severe bacterial infections during and after their hospital stays for a 9 month period.<\/p>\n

Study results indicated that a higher body mass index (BMI) was associated with a higher chance of survival at 28 days and 1 year after hospitalization. Scientists found that 26 percent of patients with a normal BMI \u201cwere dead within a year\u201d compared to 9-17 percent of patients with a higher BMI.\u00a0 These findings help to confirm the \u201cobesity survival paradox\u201d where being overweight and obese may help defend against serious bacterial infections. \u00c5sa Alsi\u00f6, the study\u2019s first and corresponding author and senior consultant in infectious diseases at Sk\u00f6vde, said \u201cin the context of most other diseases, overweight and obesity are disadvantageous\u201d and \u201cparadoxically, it\u2019s the other way round here.\u201d<\/p>\n

Gunnar Jacobsson, senior study author and senior consultant in infectious diseases at Sk\u00f6vde, related their findings to the COVID-19 pandemic where \u201coverweight people have been hit hard.\u201d He believes that more experience with patients suffering from serious bacterial infections could help to improve outcomes for COVID-19 and overweight patients. Jacobbson stated that \u201cmore knowledge is needed to shed light on how body weight affects the body\u2019s defenses against infection, so that treatment can be individualized.\u201d<\/p>\n

With obesity increasing at alarming rates, Alsi\u00f6 and the team of researchers conclude that population level studies are needed to see how BMI influences outcomes for patients with infectious diseases and to determine what connections exist that regulate the immune system.<\/p>\n<\/div><\/div>

Click here to read the full article.<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div>

\n\n